TipRanks
PhoenixBio Co., Ltd. (JP:6190)
:6190
Japanese Market
Want to see JP:6190 full AI Analyst Report?

PhoenixBio Co., Ltd. (6190) Income Statement

0 Followers

PhoenixBio Co., Ltd. Income Statement

Last quarter (Q4 2025), PhoenixBio Co., Ltd.'s total revenue was ¥364.82M, a decrease of -8.35% from the same quarter last year. In Q4, PhoenixBio Co., Ltd.'s net income was ¥32.01M. See PhoenixBio Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 1.57B¥ 1.54B¥ 1.72B¥ 2.12B¥ 1.32B
Gross Profit
¥ 1.19B¥ 1.11B¥ 1.20B¥ 1.56B¥ 727.79M
Operating Expenses
¥ 1.11B¥ 1.24B¥ 1.18B¥ 1.05B¥ 895.41M
Depreciation and Amortization
¥ 33.75M¥ 28.20M¥ 25.23M¥ 23.70M¥ 86.24M
EBITDA
¥ 116.52M¥ -396.12M¥ 87.94M¥ 537.42M¥ -305.81M
Operating Income
¥ 82.77M¥ -135.17M¥ 11.06M¥ 508.45M¥ -167.62M
Other Income/Expenses
¥ 48.67M¥ -294.39M¥ 48.72M¥ 2.20M¥ -225.38M
Pretax Income
¥ 131.44M¥ -429.56M¥ 59.78M¥ 510.64M¥ -393.00M
Net Income
¥ 125.23M¥ -445.65M¥ 26.38M¥ 493.33M¥ -387.97M
Per Share Metrics
Basic EPS
¥ 30.81¥ -110.18¥ 6.98¥ 145.23¥ -117.50
Diluted EPS
¥ 30.81¥ -110.18¥ 6.98¥ 97.29¥ -117.50
Weighted Average Shares Outstanding
4.06M 4.04M 3.78M 3.40M 3.30M
Weighted Average Shares Outstanding (Diluted)
4.06M 4.04M 3.78M 3.40M 3.30M
Currency in JPY

PhoenixBio Co., Ltd. Earnings and Revenue History